| # | Drug | Count |
|---|---|---|
| 0 | ROSUVASTATIN | 101 |
| 1 | EVOLOCUMAB | 77 |
| 2 | EZETIMIBE | 73 |
| 3 | ASPIRIN | 65 |
| 4 | ASPIRIN 325 MG | 65 |
| 5 | ASPIRIN 81 MG | 65 |
| 6 | INCLISIRAN | 43 |
| 7 | DAPAGLIFLOZIN | 31 |
| 8 | CLOPIDOGREL | 28 |
| 9 | AMLODIPINE | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FITUSIRAN | 1 | 0.0179 |
| 1 | INCLISIRAN | 43 | 0.0051 |
| 2 | BEMPEDOIC ACID | 9 | 0.0033 |
| 3 | ADALIMUMAB-AACF | 1 | 0.0030 |
| 4 | GIVINOSTAT | 1 | 0.0016 |
| 5 | LOMITAPIDE MESYLATE | 5 | 0.0013 |
| 6 | ROSUVASTATIN | 101 | 0.0012 |
| 7 | EZETIMIBE | 73 | 0.0009 |
| 8 | IVABRADINE | 6 | 0.0009 |
| 9 | NORETHINDRONE AND ETHINYL ESTRADIOL | 1 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antithrombin-directed RNA Interaction [EPC] | 1 | 0.0179 |
| 1 | Small Interfering RNA [EPC] | 1 | 0.0063 |
| 2 | PCSK9 Inhibitor [EPC] | 85 | 0.0033 |
| 3 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 9 | 0.0027 |
| 4 | Dietary Cholesterol Absorption Inhibitor [EPC] | 73 | 0.0008 |
| 5 | Provitamin D2 Compound [EPC] | 19 | 0.0006 |
| 6 | Anti-anginal [EPC] | 6 | 0.0006 |
| 7 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 8 | Calcitonin [EPC] | 1 | 0.0003 |
| 9 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 33 | 0.0003 |